Terkko Navigator / Cancer

Mind the gap: Gendered publication trends in oncology

An exercise oncology clinical pathway: Screening and referral for personalized interventions

Forty‐year trends in menopausal hormone therapy use and breast cancer incidence among postmenopausal black and white women

Gender differences in publication rates in oncology: Looking at the past, present, and future

Infigratinib in upper tract urothelial carcinoma versus urothelial carcinoma of the bladder and its association with comprehensive genomic profiling and/or cell‐free DNA results

Searching for the perfect combination of drug, disease, genetic alteration, and screening test to maximize FGFR inhibition in urothelial cancer

Global incidence trends in primary liver cancer by age at diagnosis, sex, region, and etiology, 1990‐2017

Pathfinders in oncology from the beginning of modern surgery of intracranial tumors to the introduction of the Pap smear

Medical financial hardship reported by Native Hawaiian and Pacific Islander cancer survivors compared with non‐Hispanic whites

Mutational profile of endometrial hyperplasia and risk of progression to endometrioid adenocarcinoma

Impact of the Patient Protection and Affordable Care Act on cost‐related medication underuse in nonelderly adult cancer survivors

Nativity, ethnic enclave residence, and breast cancer survival among Latinas: Variations between California and Texas

Primary dural lymphomas: Clinical presentation, management, and outcome

An evolutionary framework for treating pediatric sarcomas

Rethinking the 10‐pack‐year rule for favorable human papillomavirus–associated oropharynx carcinoma: A multi‐institution analysis

Symptom burden in patients with cancer who are experiencing unplanned hospitalization

Particle radiation therapy in the management of malignant glioma: Early experience at the Shanghai Proton and Heavy Ion Center

First person profile: Emil J. Freireich, MD

Clinician reminders increase cancer screening orders, but patients need prompts as well

Rates of anal cancer increase dramatically in the United States

Nativity, ethnic enclave residence, and breast cancer survival among Latinas: Variations between California and Texas

Primary dural lymphomas: Clinical presentation, management, and outcome

An evolutionary framework for treating pediatric sarcomas

Rethinking the 10‐pack‐year rule for favorable human papillomavirus–associated oropharynx carcinoma: A multi‐institution analysis

Symptom burden in patients with cancer who are experiencing unplanned hospitalization

Particle radiation therapy in the management of malignant glioma: Early experience at the Shanghai Proton and Heavy Ion Center

First person profile: Emil J. Freireich, MD

Clinician reminders increase cancer screening orders, but patients need prompts as well

Rates of anal cancer increase dramatically in the United States

Reply to Multidisciplinary clinics: A possible means to help to eliminate racial disparities in prostate cancer

Multidisciplinary clinics: A possible means to help to eliminate racial disparities in prostate cancer

Use of immunotherapy and surgery for stage IV melanoma

Association of adverse events and associated cost with efficacy for approved relapsed and/or refractory multiple myeloma regimens: A Bayesian network meta‐analysis of phase 3 randomized controlled trials

Trajectories of sickness absence and disability pension in the 2 years before and 3 years after breast cancer diagnosis: A Swedish longitudinal population‐based cohort study

Familial risk of breast cancer by dynamic, accumulative, and static definitions of family history

Erratum

Overcoming resistance to osimertinib in non–small cell lung cancer: Hopes, doubts, and in‐between

NRG/RTOG 1122: A phase 2, double‐blinded, placebo‐controlled study of bevacizumab with and without trebananib in patients with recurrent glioblastoma or gliosarcoma

Genomic landscape of acquired resistance to third‐generation EGFR tyrosine kinase inhibitors in EGFR T790M‐mutant non–small cell lung cancer

High triple‐negative breast cancer prevalence and aggressive prognostic factors in Barbadian women with breast cancer

Reply to potential underestimation of cerebrovascular events in the PROVENGE registry for the observation, collection, and evaluation of experience data

Potential underestimation of cerebrovascular events in the PROVENGE Registry for the observation, collection, and evaluation of experience data

Prevalence of decisional regret among patients who underwent allogeneic hematopoietic stem cell transplantation and associations with quality of life and clinical outcomes

Bias and stereotyping among research and clinical professionals: Perspectives on minority recruitment for oncology clinical trials

Bias and stereotyping among research and clinical professionals: Perspectives on minority recruitment for oncology clinical trials

Hippocampus‐avoidance whole‐brain radiation therapy with a simultaneous integrated boost for multiple brain metastases

Performance status and end‐of‐life care among adults with non–small cell lung cancer receiving immune checkpoint inhibitors

Transgender individuals' cancer survivorship: Results of a cross‐sectional study

Hippocampus‐avoidance whole‐brain radiation therapy with a simultaneous integrated boost for multiple brain metastases

Performance status and end‐of‐life care among adults with non–small cell lung cancer receiving immune checkpoint inhibitors